The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Abstract
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl). Its structure was determined by mass spectrometry and by direct comparison with a synthetic sample. 2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2--the two cannabinoid receptors identified thus far--with Ki values of 472 +/- 55 and 1400 +/- 172 nM, respectively. In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at the potency level of delta 9-tetrahydrocannabinol (delta 9-THC). Upon intravenous administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, reduction of spontaneous activity, and lowering of the rectal temperature. 2-Ara-Gl also shares the ability of delta 9-THC to inhibit electrically evoked contractions of mouse isolated vasa deferentia; however, it was less potent than delta 9-THC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most studied endogenous ligands that bind cannabinoid receptors are AEA (Devane et al, 1992) and 2arachidonoylglycerol (2-AG) (Mechoulam et al, 1995;Sugiura et al, 1995).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Mechoulam et al, 1995
In the citing paper
“Enriching the picture further, the actions of AEA are not restricted to CB1R, given that ECBs also act, sometimes in a non-retrograde manner, at CB2R [30], GPR55 [31], and TRPV1 (transient receptor potential vanilloid type 1) channels [32–34], as well as other G protein subtypes such as Gs and/or Gq11 [35,36].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [30]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Self-citationMolecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Comprehensive organic chemistry
Barton, D. H. R., & Ollis, W. D. (1978) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)85753-1 · Cited by 2,798
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Manual of pharmacologic calculations with computer programs
(1988) · International Journal of Biochemistry · doi:10.1016/0020-711x(88)90084-5 · Cited by 1,458
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 706
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 698
International Encyclopedia of Pharmacology and Therapeutics
de Jong, R. H. (1972) · Anesthesiology · doi:10.1097/00000542-197201000-00025 · Cited by 499
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 478
Compton, D. M., Rice, K. C., Costa, B., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 459
Self-citationPharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 448
Self-citationThe pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
Smith, P. B., Compton, D. M., Welch, S. P., Razdan, R. K., Mechoulam, R., & Martin, B. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22356-4 · Cited by 394
Self-citationCannabinoid‐receptor expression in human leukocytes
Bouaboula, M., Rinaldi, M. L., CARAYON, P., Carillon, C., Delpech, B., Shire, D. J., Fur, G. L., & Casellas, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 376
Gaoni, Y., & Mechoulam, R. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00730a036 · Cited by 364
Self-citationDewey, W. L., Harris, L. S., Howes, J. F., & Nuite, J. A. (1970) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28712-2 · Cited by 338
Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
Hanus, L. O., Gopher, A., Almog, S., & Mechoulam, R. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a026 · Cited by 334
Self-citationBook Review: International Encyclopedia of Pharmacology and Therapeutics
Paton, W. D. M. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706000438 · Cited by 312
Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., & Mechoulam, R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03576.x · Cited by 297
Self-citationLynn, A. B., & Herkenham, M. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 278
Cellular effects of cannabinoids.
Martin, B. R. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06860-7 · Cited by 254
Self-citationKaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 246
Self-citationInhibition of Cellular Mediated Immunity in Marihuana Smokers
Nahas, G. G., Suciu‐Foca, N., Armand, J., & Morishima, A. (1974) · Science · doi:10.1126/science.183.4123.419 · Cited by 236
Compton, D. M., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 216
Self-citationThe ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice
Pertwee, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06900.x · Cited by 189
Self-citationThe central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 179
Self-citationWeidenfeld, J., Feldman, S., & Mechoulam, R. (2008) · Neuroendocrinology · doi:10.1159/000126646 · Cited by 179
Self-citationEffects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 132
Self-citationSearch for endogenous ligands of the cannabinoid receptor
Mechoulam, R., Hanuš, L., & Martin, B. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90197-x · Cited by 126
Self-citationPertwee, R. G., Stevenson, L. A., & Griffin, G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13989.x · Cited by 111
Self-citationDrugs of abuse and immune function
WATSON, R. R. (1990) · CRC Press eBooks · Cited by 101
The evidence for the existence of cannabinoid receptors
Pertwee, R. G. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90154-p · Cited by 95
Self-citationCannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivatives
Loev, B., Bender, P. E., Dowalo, F., et al. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a002 · Cited by 56
Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia
Pertwee, R. G., Griffin, G., Hanus, L. O., et al. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90499-5 · Cited by 55
Self-citationDrugs of Abuse, Immunity, and Immunodeficiency
Friedman, H. P., Specter, S. C., & Klein, T. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8 · Cited by 47
Schatz, A. R., Kessler, F. K., & Kaminski, N. E. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90414-k · Cited by 47
Self-citationTallarida, R. J., & Murray, R. B. (1987) · Springer eBooks · doi:10.1007/978-1-4612-4974-0_9 · Cited by 36
Drugs of abuse, immunity, and immunodeficiency
Borek, F. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90183-t · Cited by 20
Effects of Marijuana on Macrophage Function
Cabral, G. A., & Vásquez, R. L. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8_10 · Cited by 17
Effect of Stereospecific Cannabinoids on the Immune System
Zimmerman, A. M., Titishov, N., Mechoulam, R., & Zimmerman, S. B. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8_8 · Cited by 7
Self-citationJärbe, T. U. C., Hiltunen, A. J., Mathis, D. A., et al. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10177-8 · Cited by 6
Research works printed but not linked: 1
- Gunston, 1979, Lipids, Vol. 5, 633
Cited by
Sorted by citations
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationGut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Metadata
- Authors
- Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., & Vogel, Z.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Michigan State University (US)
- Virginia Commonwealth University (US)
- Sheba Medical Center (IL)
- University of Aberdeen (GB)
- Weizmann Institute of Science (IL)
- Corresponding author
- Mechoulam, Raphael
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 50
- Issue
- 1
- Pages
- 83-90
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2024653583
- Cited by
- 2,913
- References
- 42
- Citations by year
- 2026: 27 · 2025: 69 · 2024: 89 · 2023: 84 · 2022: 103 · 2021: 125 · 2020: 118 · 2019: 110 · 2018: 89 · 2017: 105 · 2016: 112 · 2015: 109 · 2014: 98 · 2013: 104 · 2012: 137
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health (5r01da008169-02)
- U.S. Public Health Service
- National Institute on Drug Abuse (DA 8169, DA-3672)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- 2-arachidonoylglycerol, endocannabinoids, cannabinoid receptors, CB1 receptor, CB2 receptor, canine intestine, adenylate cyclase inhibition, forskolin, delta-9-tetrahydrocannabinol, antinociception, immobility, hypothermia, vas deferens contraction, structure elucidation
- MeSH terms
- Animals, Arachidonic Acids, Cannabinoids, Cell Line, Dogs, Glycerides, Intestines, Male, Gas Chromatography-Mass Spectrometry, Mice, Inbred ICR, Receptors, Drug, Molecular Structure, Receptors, Cannabinoid, Mice, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review